S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
BREAKING: Tiny biotech successfully treats blindness (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
BREAKING: Tiny biotech successfully treats blindness (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
BREAKING: Tiny biotech successfully treats blindness (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
BREAKING: Tiny biotech successfully treats blindness (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
BREAKING: Tiny biotech successfully treats blindness (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
BREAKING: Tiny biotech successfully treats blindness (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
BREAKING: Tiny biotech successfully treats blindness (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
BREAKING: Tiny biotech successfully treats blindness (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
LON:BSE

Base Resources - BSE Price Target & Analyst Ratings

GBX 10.75
+0.50 (+4.88%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
10.31
▼
10.88
50-Day Range
10.20
▼
14.75
52-Week Range
9.60
▼
21
Volume
249,325 shs
Average Volume
315,669 shs
Market Capitalization
£126.85 million
P/E Ratio
215.00
Dividend Yield
27.91%
Price Target
GBX 36.67

Base Resources Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 3 Analyst Ratings

Consensus Analyst Price Target

GBX 36.67
High PredictionGBX 50
Average PredictionGBX 36.67
Low PredictionGBX 24
TypeCurrent
4/1/22 to 4/1/23		1 Month Ago
3/2/22 to 3/2/23		3 Months Ago
1/1/22 to 1/1/23		1 Year Ago
4/1/21 to 4/1/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 36.67GBX 36.67GBX 42.50GBX 29.50
Get Base Resources Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BSE and its competitors with MarketBeat's FREE daily newsletter.

BSE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BSE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Base Resources Stock vs. The Competition

TypeBase ResourcesBasic Materials Companies
Consensus Rating Score
3.00
2.58
Consensus RatingBuyBuy
News Sentiment RatingNeutral News
Neutral News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/27/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 50+257.14%
2/23/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 36+182.35%
1/24/2023Peel Hunt
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 24+88.24%
10/25/2022Shore Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingHouse Stock
10/19/2021Peel Hunt
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 21+35.05%
(Data available from 4/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BSE Price Target - Frequently Asked Questions

What is Base Resources's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Base Resources stock is Buy based on the current 3 buy ratings for BSE. The average twelve-month price prediction for Base Resources is GBX 36.67 with a high price target of GBX 50 and a low price target of GBX 24. Learn more on BSE's analyst rating history.

Do Wall Street analysts like Base Resources more than its competitors?

Analysts like Base Resources more than other Basic Materials companies. The consensus rating score for Base Resources is 3.00 while the average consensus rating score for basic materials companies is 2.58. Learn more on how BSE compares to other companies.

Does Base Resources's stock price have much upside?

According to analysts, Base Resources's stock has a predicted upside of 178.48% based on their 12-month price targets.

What analysts cover Base Resources?

Base Resources has been rated by Berenberg Bank, Canaccord Genuity Group, and Peel Hunt in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (LON:BSE) was last updated on 4/1/2023 by MarketBeat.com Staff